Postmarketing surveillance is monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.
Our skilful global team tailor-make solutions for any clinical and post-marketing pharmacovigilance (PV) obligations, compliant with EMA, FDA and ICH. We ensure that this is a comprehensive yet cost-effective process, enabling full compliance with legal requirements. We have a team of fully qualified medical professionals acting as QPPV’s with European, US or Global coverage.
We provide a comprehensive range of drug safety services to help minimize risk and protect patient well-being.
Clinical trial participants help us speed breakthroughs in modern drug development. Our job is to protect them. From versatile technologies and targeted data collection and analysis to in-depth reporting and regulatory compliance, we provide a comprehensive range of pharmacovigilance services throughout the product life cycle to detect, assess, understand, and prevent adverse effects or any other drug-related issues, ultimately making patients’ lives better.